More recently, the inhibition of asparagine endopeptidase (AEP, a protease responsible for the cleavage of its substrates after asparagine residues) with small molecular inhibitors has been suggested as a potential target for AD, because it is thought to play a role in the pathological processing of the amyloid precursor protein and tau proteins. This evidence concerns the gene LGMN and Alzheimer disease.